Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features M Heath, N Jaimes, B Lemos, A Mostaghimi, LC Wang, PF Peñas, ... Journal of the American Academy of Dermatology 58 (3), 375-381, 2008 | 1115 | 2008 |
A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention AC Chen, AJ Martin, B Choy, P Fernández-Peñas, RA Dalziell, ... New England journal of medicine 373 (17), 1618-1626, 2015 | 647 | 2015 |
Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature SG Gupta, LC Wang, PF Penas, M Gellenthin, SJ Lee, P Nghiem Archives of Dermatology 142 (6), 685-690, 2006 | 431 | 2006 |
Bed bugs: clinical relevance and control options SL Doggett, DE Dwyer, PF Peñas, RC Russell Clinical microbiology reviews 25 (1), 164-192, 2012 | 404 | 2012 |
Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: a single-institution cohort SJE Hwang, G Carlos, D Wakade, K Byth, BY Kong, S Chou, MS Carlino, ... Journal of the American Academy of Dermatology 74 (3), 455-461. e1, 2016 | 296 | 2016 |
Cutaneous toxicities of RAF inhibitors R Anforth, P Fernandez-Peñas, GV Long The lancet oncology 14 (1), e11-e18, 2013 | 237 | 2013 |
Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma RM Anforth, T Blumetti, RF Kefford, R Sharma, RA Scolyer, S Kossard, ... British Journal of Dermatology 167 (5), 1153-1160, 2012 | 187 | 2012 |
Quality of life in mild to moderate acne: relationship to clinical severity and factors influencing change with treatment M Jones‐Caballero, MM Chren, B Soler, E Pedrosa, PF Peñas Journal of the European Academy of Dermatology and Venereology 21 (2), 219-226, 2007 | 172 | 2007 |
Cutaneous toxic effects of BRAF inhibitors alone and in combination with MEK inhibitors for metastatic melanoma G Carlos, R Anforth, A Clements, AM Menzies, MS Carlino, S Chou, ... JAMA dermatology 151 (10), 1103-1109, 2015 | 169 | 2015 |
Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc KG Paulson, BD Lemos, B Feng, N Jaimes, PF Peñas, X Bi, E Maher, ... Journal of Investigative Dermatology 129 (6), 1547-1555, 2009 | 158 | 2009 |
Diagnostic and neural analysis of skin cancer (DANAOS). A multicentre study for collection and computer‐aided analysis of data from pigmented skin lesions using digital dermoscopy K Hoffmann, T Gambichler, A Rick, M Kreutz, M Anschuetz, T Grünendick, ... British Journal of Dermatology 149 (4), 801-809, 2003 | 156 | 2003 |
Tetraspanins are localized at motility-related structures and involved in normal human keratinocyte wound healing migration PF Peñas, A García-Díez, F Sánchez-Madrid, M Yáñez-Mó Journal of investigative dermatology 114 (6), 1126-1135, 2000 | 143 | 2000 |
Sclerodermatous graft-vs-host disease: clinical and pathological study of 17 patients PF Peñas, M Jones-Caballero, M Aragüés, J Fernández-Herrera, J Fraga, ... Archives of dermatology 138 (7), 924-934, 2002 | 132 | 2002 |
A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab G Carlos, R Anforth, S Chou, A Clements, P Fernandez-Peñas Melanoma research 25 (3), 265-268, 2015 | 125 | 2015 |
Toxic epidermal necrolysis–like reaction with severe satellite cell necrosis associated with nivolumab in a patient with ipilimumab refractory metastatic melanoma N Nayar, K Briscoe, PF Penas Journal of immunotherapy 39 (3), 149-152, 2016 | 118 | 2016 |
The Spanish version of Skindex‐29 M Jones‐Caballero, PF Peñas, A García‐Díez, X Badía, MM Chren International journal of dermatology 39 (12), 907-912, 2000 | 105 | 2000 |
Perforating granuloma annulare PF Peñas, M Jones‐Caballero, J Fraga, J Sánchez‐Pérez, A García‐Díez International journal of dermatology 36 (5), 340-348, 1997 | 100 | 1997 |
Quality of life in non‐melanoma skin cancer C Gaulin, DF Sebaratnam, P Fernández‐Peñas Australasian Journal of Dermatology 56 (1), 70-76, 2015 | 95 | 2015 |
Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆ ME Lacouture, V Sibaud, PA Gerber, C Van den Hurk, ... Annals of Oncology 32 (2), 157-170, 2021 | 87 | 2021 |
The microbiome and atopic eczema: More than skin deep CL Thomas, P Fernández‐Peñas Australasian Journal of Dermatology 58 (1), 18-24, 2017 | 83 | 2017 |